Yingqiu Y Liu
Overview
Explore the profile of Yingqiu Y Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheng H, Hong B, Zhou L, Allen J, Tai G, Humphreys R, et al.
Cell Cycle
. 2012 Aug;
11(17):3312-23.
PMID: 22895172
The discovery of the molecular targets of chemotherapeutic medicines and their chemical footprints can validate and improve the use of such medicines. In the present report, we investigated the effect...
2.
Mayes P, Dolloff N, Daniel C, Liu J, Hart L, Kuribayashi K, et al.
Cancer Res
. 2011 Jun;
71(15):5265-75.
PMID: 21646472
Tumor hypoxia is an inherent impediment to cancer treatment that is both clinically significant and problematic. In this study, we conducted a cell-based screen to identify small molecules that could...
3.
Zhang H, Qiao H, Bakken A, Gao F, Huang B, Liu Y, et al.
Acad Radiol
. 2010 Dec;
18(1):3-12.
PMID: 21145025
Rationale And Objectives: Firefly luciferase (Fluc) reporter gene is an authentic marker for surviving stem cells. However, it is unable to visualize the intramyocardial delivery of stem cells or their...
4.
Dews M, Fox J, Hultine S, Sundaram P, Wang W, Liu Y, et al.
Cancer Res
. 2010 Oct;
70(20):8233-46.
PMID: 20940405
c-Myc stimulates angiogenesis in tumors through mechanisms that remain incompletely understood. Recent work indicates that c-Myc upregulates the miR-17∼92 microRNA cluster and downregulates the angiogenesis inhibitor thrombospondin-1, along with other...
5.
Plastaras J, Kim S, Liu Y, Dicker D, Dorsey J, McDonough J, et al.
Cancer Res
. 2007 Oct;
67(19):9443-54.
PMID: 17909054
The antineoplastic drug sorafenib (BAY 43-9006) is a multikinase inhibitor that targets the serine-threonine kinase B-Raf as well as several tyrosine kinases. Given the numerous molecular targets of sorafenib, there...
6.
Ricci M, Kim S, Ogi K, Plastaras J, Ling J, Wang W, et al.
Cancer Cell
. 2007 Jul;
12(1):66-80.
PMID: 17613437
Cells expressing oncogenic c-Myc are sensitized to TNF superfamily proteins. c-Myc also is an important factor in determining whether a cell is sensitive to TRAIL-induced apoptosis, and it is well...